This also led to an improved mdx-associate muscle pathology, confirming that postnatal deletion of Flt1 is able to rescue the dystrophinopathy related muscle pathology. Here, FLT1 is linked to neuromuscular disease caused by qualitative or quantitative defects of dystrophin.